Research news
- 20 August 2010
Critical breakthrough in understanding facioscapulohumeral muscular dystrophy Research from the Netherlands has given new insight into the genetics of FSH which will help the development of targeted treatments in the future - 18 August 2010
Funding gained for follistatin gene therapy trial: an approach applicable to a wide range of conditions Researchers in Ohio have gained funding for a clinical trial injecting a virus carrying a muscle growth stimulating gene into people with Becker muscular dystrophy and inclusion body myositis - 16 August 2010
Highlights from the International Congress on Neuromuscular Diseases Our Research Communications Officer Dr Kristina Elvidge summarises her highlights from the congress which include the latest in gene and exercise therapy, better steroids for Duchenne and a treatment advance for periodic paralysis. - 5 August 2010
Potential Duchenne drug ACE-031 allowed on the fast track to approval Acceleron Pharma has gained FDA Fast Track designation for ACE-031; a potential treatment for Duchenne muscular dystrophy and other conditions. - 3 August 2010
Disappointing results from BioMarin’s utrophin clinical trial for Duchenne BioMarin has announced disappointing results from the Phase I clinical trial of 'BMN-195’. It was hoped BMN-195 would able to increase the amount of utrophin protein in boys with Duchenne. - 15 July 2010
Prof. Alan Emery and Lord John Walton honoured at International Congress on Neuromuscular Diseases Prof. Alan Emery and Lord John Walton have been honoured at the International Congress on Neuromuscular Diseases in Naples. - 12 July 2010
Report published on FSHD standards of care and clinical trial readiness A report based on a recent ENMC workshop has given expert recommendations on standards of care and steps needed to be ready for future clinical trials for facioscapulohumeral muscular dystrophy (FSHD) - 1 July 2010
Non-invasive blood test may be available for genetic testing in early pregnancy in five years A researcher from the Netherlands has presented findings stating it could be possible to develop a cheap, non-invasive blood test to detect certain genetic abnormalities early in pregnancy. - 25 June 2010
Prosensa and GSK announce plans to further develop exon skipping for Duchenne Prosensa and GlaxoSmithKline have initiated pre-clinical development of four new molecular patches and have started a clinical trial to test the safety of exon skipping in Duchenne patients who are unable to walk. - 11 June 2010
New treatment strategy discovered for oculopharyngeal muscular dystrophy Muscular Dystrophy Campaign and Wellcome Trust funded research has found that a chemical called cystamine reduced the symptoms of OPMD in a mouse model of the condition.
